Advertisement

Zirkadianes Blutdruckprofil. Neue Aspekte in der Therapiekontrolle der arteriellen Hypertonie mit ACE-Inhibitoren?

  • W. Meyer-Sabellek
  • K.-L. Schulte
  • K. Liederwald
  • R. . Gotzen
Conference paper
  • 10 Downloads

Zusammenfassung

Kommerziell verfügbare validierte tragbare Monitore ermöglichen, den systolischen und diastolischen Blutdruck sowie die Herzfrequenz unter Alltagsbedingungen (z. B. am Arbeitsplatz, in der Praxis, während des Schlafs) weitestgehend zuverlässig zu registrieren [1, 2]. Das ambulante Blutdruckmonitoring (ABPM) zur Diagnose der „Weißkittelhypertonie“ [3, 4], zur Ermittlung des Schweregrades bei arteriellem Bluthochdruck und zur Beurteilung der Wirksamkeit blutdrucksenkender Medikationen [5–7] kann über die punktuelle Aussage der Gelegenheitsblutdruckmessung das individuelle biphasische diurnale Blutdruckprofil erfassen. Eine besondere Bedeutung kann der ABPM bei der Beurteilung von Antihypertensiva mit unterschiedlichen Plasmahalbwertszeiten mit zukommen Die vorliegende Arbeit gibt einen Überblick über den blutdrucksenkenden Effekt peroraler ACE-Hemmer auf das zirkadiane Blutdrucktagesprofil.

Literatur

  1. 1.
    Pickering TG, Harshfield GA, Devereux RB, Laragh JH (1985) What is the role of ambulatory blood pressure monitoring in the management of hypertensive patients? Hypertension 7: 171–177PubMedCrossRefGoogle Scholar
  2. 2.
    Meyer-Sabellek W, Schulte K-L, Distler A, Gotzen R (1989) Methodological development and problems of recorders for automatic inidirect ambulatory 24-hour monitoring of blood pressure. In: Meyer-Sabellek W, Anlauf M, Gotzen R, Steinfeld L (eds) Blood pressure measurements. New techniques in automatic indirect monitoring. Steinkopff/ Springer, Darmstadt New York, pp 127–140Google Scholar
  3. 3.
    Mancia G, Bertinieri G, Grassi G, Parati G, Pomidossi G et al. (1983) Effects of blood pressure measurement by the doctor on patients’ blood pressure and heart rate. Lancet II: 695 — 698Google Scholar
  4. 4.
    Pickering TG, James GD, Harshfield GA, Blank S, Laragh JH (1988) How common is white coat hypertension? JAMA 259: 225–228PubMedCrossRefGoogle Scholar
  5. 5.
    O’Brien E, Cox JP, O’Malley K (1984) Ambulatory blood pressure measurement in the evaluation of blood pressure lowering drugs. J Hypertens 7: 243–247Google Scholar
  6. 6.
    Meyer-Sabellek W, Schulte K-L, Streitberg B, Gotzen R (1988) Two-year follow-up of 24-hour indirect blood pressure monitoring. Drugs 36 (Suppl 6): 106–112CrossRefGoogle Scholar
  7. 7.
    Waeber B, Burnier M, Perret F, Nussberger J, Brunner HR (1980) Ambulatory blood pressure measurement and antihypertensive therapy. J Hypertens 7 (Suppl 3): 33–39Google Scholar
  8. 8.
    Statement (1990) zur ambulanten 24-Stunden-Blutdruckmessung. Z Kardiol (im Druck)Google Scholar
  9. 9.
    Consensus Document (1990) on Indirect Ambulatory Monitoring. J Hypertens (im Druck)Google Scholar
  10. 10.
    Lemmer B (1989) Temporal aspects of the effects of cardiovascular active drugs in humans. In: Lemmer B (ed) Chronopharmacology. Dekker, New York, p 525–541Google Scholar
  11. 11.
    Moore-Ede MC, Czeisler CA, Richardson GS (1983) Circadian time-keeping in health and disease (part 2). Clinical implications of circadian rhythmicity. N Engl J Med 309: 530–535Google Scholar
  12. 12.
    Willich SN, Levy D, Rocco MB, Toiler GM, Stone PH, Muller JE (1987) Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol 60: 801–806PubMedCrossRefGoogle Scholar
  13. 13.
    Mulcahy D, Cunningham D, Cream P (1988) Circadian variation of total ischaemic burden and its alteration with antianginal agents. Lancet IL•755–759Google Scholar
  14. 14.
    Bootsma F, de Bruijn J, Derkx F, Schalekamp M (1981) Opposite effects of captopril on angiotensin I converting enzyme activity and concentration; relation between enzyme inhibition and long-term blood pressure respone. Clin Sci 60: 491–496Google Scholar
  15. 15.
    De Cesaris R, Ranieri G, Salzano EV, Liberatore SM (1987) Once daily therapy with angiotensin converting enzyme inhibitors in mild hypertension: a comparison of captopril and enalapril. J Hypertens 5 (Suppl 5): 595–597Google Scholar
  16. 16.
    De Gaudemaris R, Battistella P, Siche JP, Debru JL, Blatier JF, Mallion JM (1986) Comparative study of the efficacy of captopril at a single daily dose of 100 mg and at a twice daily dose of 50 mg by measuring ambulatory pressure over 24 hours. Postgrad Med J 62 (Suppl 1): 97–100PubMedGoogle Scholar
  17. 17.
    Germano G, Damini S, Germano U, Pecchioli V, Pica B, Antonini P (1990) Evaluations of the effect-duration of once daily enalapril compared with once daily captopril. Nephron 55 (Suppl 1): 65–69PubMedCrossRefGoogle Scholar
  18. 18.
    Lacourciere L, Provencher P (1989) Comparative effects of zofenopril and hydrochlorothiazide on office and ambulatory blood pressures in mild to moderate essential hypertension. Br J Clin Pharmac 27: 371–376CrossRefGoogle Scholar
  19. 19.
    Heber ME, Bridgen GS, Caruana MP, Lahiri A, Raftery EB (1988) First dose response and 24-hour antihypertensive efficacy of new once-daily angiotensin converting enzyme inhibitor, ramipril. Am J Cardiol 62: 239–245PubMedCrossRefGoogle Scholar
  20. 20.
    Jones RI, Hornung RS, Cashman PMM, Raftery EB (1984) Duration and diurnal variation of the hypotensive effect of enalapril in patients with essential hypertension. Am J Cardiol 53: 105–108CrossRefGoogle Scholar
  21. 21.
    Lenz T, Distler A, Haller H, Meyer-Sabellek W, Wilp C, Tansey MJ, Eckert HG, Metzger H, Irmisch R, Philipp T (1986) Humoral and blood pressure effects of the angiotensin converting enzyme inhibitor ramipril in essential hypertension. Arzneim Forsch Drug Res 36 /11: 1693–1696Google Scholar
  22. 22.
    West JNW, Smith SA, Stallard T, Littler WA (1989) Effects of perindopril on ambulatory intra-arterial blood pressure, cardiovascular reflexes and forearm blood flow in essential hypertension. J Hypertens 7: 97–104PubMedCrossRefGoogle Scholar
  23. 23.
    Zachariah PK, Sheps SG, Schwartz GL, Schirger A, Ilstrup DM, Long CR, Carlson CA (1988) Antihypertensive efficacy of lisinopril. Ambulatory blood pressure monitoring. Am J Hypertens 1 (Suppl): 274–279CrossRefGoogle Scholar
  24. 24.
    Schulte KL, Meyer-Sabellek W, Liederwald K, van Gemmeren D, Gotzen R (1990) Parallel reduction of left ventricular hypertrophy and vascular resistance by vasodilator therapy. J Hypertens 8 (Suppl 3): 817Google Scholar
  25. 25.
    Schrader J (1990) Comparison of the antihypertensive efficiency of different drugs using ambulatory 24 hours blood pressure monitoring. In: Temporal Variations of the Cardiovascular System. ( Abstracts) Schattauer, StuttgartGoogle Scholar
  26. 26.
    Meyer-Sabellek WA, Schulte K-L, Liederwald K, van Gemmeren D, Gotzen R (1990) Blood pressure profile and cardiac risk in hypertensive patients with left ventricular hypertrophy. J Hypertens (in press)Google Scholar
  27. 27.
    Rowlands DB, Glover DR, Ireland MA et al. (1982) Assessment of left ventricular mass and its response to antihypertensive treatment. Lancet 1: 467–470PubMedCrossRefGoogle Scholar
  28. 28.
    Devereux RB (1987) Detection of left ventricular hypertrophy of M-mode echorcardiography. Anatomic validation, standardization, and comparison to other methods. Hypertension 9 (Suppl II): 18–26CrossRefGoogle Scholar
  29. 29.
    Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, Porcellati C (1990) Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 81: 528–536PubMedCrossRefGoogle Scholar
  30. 30.
    White WB, Dey HM, Schulman P (1989) Assessment of the daily blood pressure load as a determinant of cardiac function in patients with mild-to-moderate hypertension. Am Heart J 118 /4: 782–795PubMedCrossRefGoogle Scholar
  31. 31.
    Gosse P, Roudaut R, Reynaud P, Jullien E, Dallocchio M (1989) Relationship between left ventricular mass and noninvasive monitoring of blood pressure. AHJ 2: 631–633Google Scholar
  32. 32.
    O’Brien E, Sheridan J, O’Malley K (1988) Dippers and non-dippers. Lancet II: 397–399Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • W. Meyer-Sabellek
  • K.-L. Schulte
  • K. Liederwald
  • R. . Gotzen

There are no affiliations available

Personalised recommendations